TrademarkOpen
Search / United States / 98536018

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Service Mark

LAUNCHPAD

Allowed — statement of use stage
Second Extension - Granted
Used for: custom manufacturing of biopharmaceutical preparations for cell therapy · Testing, research, and development of…
Show more

Class 40: custom manufacturing of biopharmaceutical preparations for cell therapy
Class 42: Testing, research, and development of biopharmaceutical preparations for cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell therapy; scientific research services, clinical research, and pre-clinical research in the field of cell therapy; consulting services in the fields of biopharmaceutical research and development and genetic science

Class 40 – Materials treatmentClass 42 – Technology & SaaS

Status timeline

  1. 6 May 2024
    Application filed
    New Application Entered
  2. 25 Aug 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 26 Sep 2024
    Response to office action filed
    Teas Response To Office Action Received
  4. 20 Mar 2025
    Approved for publication
    Approved For Pub - Principal Register
  5. 15 Apr 2025
    Published for opposition
    Published For Opposition
  6. 10 Jun 2025
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  7. 18 Nov 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  8. 29 May 2026
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
All 24 events
2026-05-30Notice Of Approval Of Extension Request E-Mailed
2026-05-29Sou Teas Extension Received
2026-05-29Sou Extension 2 Filed
2026-05-29Sou Extension 2 Granted
2025-11-19Notice Of Approval Of Extension Request E-Mailed
2025-11-18Sou Teas Extension Received
2025-11-18Sou Extension 1 Filed
2025-11-18Sou Extension 1 Granted
2025-06-10Noa Mailed - Sou Required From Applicant
2025-04-15Published For Opposition
2025-04-15Official Gazette Publication Confirmation E-Mailed
2025-04-09Notification Of Notice Of Publication E-Mailed
2025-03-24Law Office Publication Review Completed
2025-03-20Approved For Pub - Principal Register
2024-11-22Assigned To Lie
2024-11-22Combined Examiner's Amendment/Priority Action Entered
2024-09-26Teas Response To Office Action Received
2024-08-30Examiners Amendment And/Or Priority Action - Completed
2024-08-30Combined Examiner's Amendment/Priority Action Automatic Entry
2024-08-30Examiner's Amendment/Priority Action E-Mailed
2024-08-30Notification Of Examiner's Amendment/Priority Action E-Mailed
2024-08-25Assigned To Examiner
2024-05-06New Application Entered
2024-05-06New Application Office Supplied Data Entered

Goods & services by class

Class 40 Materials treatment

custom manufacturing of biopharmaceutical preparations for cell therapy

Class 42 Technology & SaaS

Testing, research, and development of biopharmaceutical preparations for cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell therapy; scientific research services, clinical research, and pre-clinical research in the field of cell therapy; consulting services in the fields of biopharmaceutical research and development and genetic science

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 31 May 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.